Using human monoclonal antibodies to prevent and treat viral diseases
Davide Corti, PhD
Vir Biotechnology, Switzerland
The development of effective countermeasures is paramount to curb the pandemic spread caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 spike (S) glycoprotein promotes entry into host cells and is the main target of neutralizing antibodies. In this talk Dr. Corti will present data on the key structural and functional features of multiple classes of SARS-CoV2 neutralizing antibodies isolated from COVID-19 immune donors.
The International Society for Antiviral Research (ISAR) is an internationally recognized organization for scientists involved in basic, applied, and clinical aspects of antiviral research. The Society main event is the annual International Conference on Antiviral Research (ICAR), a truly interdisciplinary meeting which attracts the interest of chemists, biologists, and clinicians.